Estaremos participando da InnoPharma, a inscrição é gratuita, aproveite e venha conversar conosco em nosso Stand - 097 Rua G
e-mail mkt ed01 - abril.
Fonte: FCE Pharma 2018
24/03/18 - Sem aval da Anvisa (Agência Nacional de Vigilância Sanitária), o Ministério da Saúde estuda derrubar em editais de compras a exigência de documento que afere a autenticidade de remédios importados. Sem ele, há risco de entrada de drogas falsificadas. À Folha, o ministro Ricardo Barros (Saúde) disse que a medida valerá apenas para compras determinadas judicialmente --que no ano passado somaram R$ 1 bilhão. Nesses casos, há dispensa de licitação —...
This article presents a detailed summary of the drug GMP warning letters issued in FY2017 as well as a comparison of trends since fiscal year 2013. A comprehensive GMP intelligence program includes evaluation of health authority enforcement actions including FDA forms-483, warning letters, seizures, recalls and consent decree agreements. This allows manufacturers and sponsors to identify new trends and focus of FDA inspectors and act to address or justif...
Manufacturers can benefit from this alternative transfer technology that has now been adapted to solve issues in aseptic handling.
Fonte: Reducing Bioburden Risks In Aseptic Manufacturing
The long-awaited draft of the new Annex 1 was published in December 2017. Besides mainly contents concerning sterile production, it also contains various updates on the …
Fonte: Impact of the Annex 1 Revision on Pharmaceutical Water - ECA Academy
Manufacturing and Importation Authorisation holders must not change the terms of the authorisation without prior approval of the authority. But also other GMP related changes …
Fonte: Changes which lead to a GMP Inspection - ECA Academy
In the current EU GMP Annex 1, the monitoring of 0.5 and 5 µm particles in clean rooms is a requirement. It refers to technical document ISO 14644, Part 1 for measurement. …
Fonte: The new Annex 1 and 5 µm Particles - ECA Academy